Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

TETRAPHASE PHARMACEUTICALS INC (TTPH) Class Action Lawsuit (June 2019)

Closed

1:19cv11282 • June 10, 2019

Class Period Start

March 8, 2017

Class Period End

February 13, 2018

PSLRA Deadline

September 25, 2018

Case Allegations

10b5 + Sec11

10b-5 Statutes of Repose

Mar 8, 2020

Sec11 Statutes of Repose

Jul 27, 2020

Country

United States

Court

Federal Court

Docket History

Oct 1, 2019

Voluntary Dismissal

The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.

Aug 2, 2019

Appointment of Lead Plaintiff

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Jul 27, 2018

First Filed Complaint

A securities fraud class action complaint has been filed on behalf of certain investors in TETRAPHASE PHARMACEUTICALS INC.

TOP